NRC
NRC Health
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
+17/100
Last price
20.08
▼ 0.70 (3.37%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
20.86
Prev close
20.78
Day high
20.86
Day low
20.06
Volume
80.01K
Market cap
$444.16M
P/E (TTM)
83.67
52W range
11.01 – 23.68
Day trading desk
Gap from prior close
+0.38%
Prior close 20.78
VWAP
20.17
-0.42% from price
Relative volume
1.23×
Normal
Session range
3.99%
20.06 – 20.86
Position in range
3%
Near session low
ATR (14D)
1.03
5.13% of price
Prior day high
21.15
PDH
Prior day low
20.22
PDL
Bid / ask spread
—
Quote not published
Session volume
142.48K
Avg 115.99K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.61%
-6.6%
1M
-6.73%
-7.9%
3M
-8.18%
-12.7%
6M
+17.84%
-0.3%
YTD
+6.98%
-7.3%
1Y
+64.46%
+48.0%
3Y
-54.74%
-137.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on NRC open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
11.01M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 23, 26 | LOCKHART STEPHEN H Director |
STOCK | 7.70K | $0 | Direct |
| Jun 23, 26 | WHEELER PENNY ANN Director |
STOCK | 7.70K | $0 | Direct |
| Jun 23, 26 | BHANDARI PARUL Director |
STOCK | 7.70K | $0 | Direct |
| Jun 23, 26 | NUNNELLY JOHN N Director |
STOCK | 7.70K | $0 | Direct |
| Jun 23, 26 | BERWICK DONALD M M.D. Director |
STOCK | 7.70K | $0 | Direct |
| Mar 12, 26 | RAU JASON RUSSELL Officer |
STOCK | 60.00K | $0 | Direct |
| Feb 17, 26 | HARRISON SHANE R Chief Financial Officer |
BUY | 8.00K | $98.16K | Indirect |
| Jan 5, 26 | BURIK DAVID Officer |
STOCK | 100.00K | $0 | Direct |
| Jan 5, 26 | HAYS MICHAEL D Chairman of the Board |
CONVERSION | 9.14K | $139.28K | Direct |
| Dec 15, 25 | HRDY HELEN Chief Operating Officer |
CONVERSION | 12.35K | $188.03K | Direct |
| Sep 29, 25 | HARRISON SHANE R Chief Financial Officer |
STOCK | 172.00K | $0 | Direct |
| Jul 31, 25 | FREEMAN JORDAN NICOLE Officer |
BUY | 771 | $10.00K | Direct |
| May 30, 25 | GREEN TRENT S. Chief Executive Officer |
STOCK | 500.00K | $0 | Direct |
| May 12, 25 | BEANS PATRICK E Beneficial Owner of more than 10% of a Class of Security |
BUY | 2.50K | $33.97K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BEANS PATRICK E |
Beneficial Owner of more than 10% of a Class of Security | 35.00K | Purchase |
BURIK DAVID |
Officer | 100.00K | Stock Award(Grant) |
GREEN TRENT S. |
Chief Executive Officer | 500.00K | Stock Award(Grant) |
HARRISON SHANE R |
Chief Financial Officer | — | Purchase |
HAYS MICHAEL D |
Chairman of the Board | 96.25K | Conversion of Exercise of derivative security |
HRDY HELEN |
Chief Operating Officer | 140.52K | Conversion of Exercise of derivative security |
MONNICH ANDREW |
Officer | 100.00K | Stock Award(Grant) |
NUNNELLY JOHN N |
Director | 40.36K | Stock Award(Grant) |
RAU JASON RUSSELL |
Officer | 60.00K | Stock Award(Grant) |
WHEELER PENNY ANN |
Director | 7.70K | Stock Award(Grant) |
Fundamentals
Market cap$444.16M
Enterprise value$531.28M
Revenue (TTM)$140.00M
Gross profit$86.45M
EBITDA$26.68M
Net income$5.48M
EPS (TTM)$0.24
Free cash flow$20.28M
Total cash$3.33M
Total debt$90.45M
Book value / share$0.30
Shares outstanding22.12M
Float11.82M
Short % of float28.48%
Dividend yield3.18%
Beta (5Y)0.28
Valuation & profitability ratios
Trailing P/E83.67
Forward P/E19.12
PEG ratio1.32
Price / sales—
Price / book67.84
EV / revenue3.80
EV / EBITDA19.92
Gross margin61.75%
Operating margin-0.22%
Profit margin4.18%
Return on equity42.03%
Return on assets8.13%
Debt / equity1,381.07
Current ratio0.65
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $137.39M | $143.06M | $148.58M | $151.57M | -4.0% |
| Operating revenue | $137.39M | $143.06M | $148.58M | $151.57M | -4.0% |
| Cost of revenue | $52.37M | $56.93M | $56.02M | $57.05M | -8.0% |
| Gross profit | $85.02M | $86.13M | $92.56M | $94.52M | -1.3% |
| Selling, general & admin | $54.80M | $44.91M | $46.62M | $42.70M | +22.0% |
| Total operating expense | $62.43M | $50.93M | $52.52M | $47.98M | +22.6% |
| Operating income | $22.59M | $35.19M | $40.05M | $46.54M | -35.8% |
| Net interest income | -$4.65M | -$2.47M | -$42.00K | -$1.04M | -88.3% |
| Pre-tax income | $17.84M | $32.69M | $39.96M | $42.81M | -45.4% |
| Tax provision | $6.25M | $7.91M | $8.99M | $11.02M | -21.0% |
| Net income | $11.60M | $24.78M | $30.97M | $31.80M | -53.2% |
| Net income to common | $11.29M | $24.78M | $30.96M | $31.78M | -54.4% |
| Basic EPS | 0.50 | 1.05 | 1.26 | 1.28 | -52.4% |
| Diluted EPS | 0.50 | 1.04 | 1.25 | 1.27 | -51.9% |
| EBIT | $22.61M | $35.28M | $40.82M | $44.02M | -35.9% |
| EBITDA | $30.23M | $41.31M | $46.72M | $49.30M | -26.8% |
| Basic shares | 22.38M | 23.70M | 24.54M | 24.92M | -5.6% |
| Diluted shares | 22.40M | 23.74M | 24.67M | 25.05M | -5.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.14M | $4.23M | $6.65M | $25.03M | -2.2% |
| Cash & short-term investments | $4.14M | $4.23M | $6.65M | $25.03M | -2.2% |
| Accounts receivable | $11.11M | $11.05M | $12.38M | $14.46M | +0.5% |
| Total current assets | $20.21M | $19.60M | $24.36M | $43.72M | +3.1% |
| Property, plant & equipment | $40.47M | $38.27M | $30.27M | $17.80M | +5.8% |
| Goodwill & intangibles | $68.38M | $68.77M | $63.09M | $63.23M | -0.6% |
| Total assets | $134.88M | $132.54M | $122.44M | $130.46M | +1.8% |
| Total current liabilities | $36.62M | $35.86M | $36.20M | $33.42M | +2.1% |
| Current debt | $4.01M | $4.79M | $7.21M | $4.49M | -16.2% |
| Long-term debt | $75.02M | $57.90M | $29.47M | $17.69M | +29.6% |
| Total debt | $79.03M | $62.68M | $36.68M | $22.18M | +26.1% |
| Total liabilities | $120.89M | $101.25M | $73.48M | $58.43M | +19.4% |
| Retained earnings | -$17.30M | -$17.06M | -$30.53M | -$25.18M | -1.4% |
| Shareholder equity | $13.99M | $31.28M | $48.95M | $72.03M | -55.3% |
| Working capital | -$16.41M | -$16.26M | -$11.84M | $10.30M | -0.9% |
| Net tangible assets | -$54.39M | -$37.48M | -$14.13M | $8.81M | -45.1% |
| Shares issued | 31.97M | 31.07M | 31.00M | 30.92M | +2.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $11.60M | $24.78M | $30.97M | $31.80M | -53.2% |
| Depreciation & amortisation | $7.62M | $6.02M | $5.90M | $5.28M | +26.6% |
| Stock-based compensation | $3.31M | $284.00K | $935.00K | $1.20M | +1,066.2% |
| Change in working capital | $916.00K | $3.81M | $986.00K | -$3.35M | -76.0% |
| Operating cash flow | $26.45M | $34.63M | $38.11M | $36.27M | -23.6% |
| Capital expenditure | -$10.71M | -$15.45M | -$15.78M | -$9.84M | +30.7% |
| Investing cash flow | -$10.71M | -$20.28M | -$15.78M | -$9.84M | +47.2% |
| Share buybacks | -$20.18M | -$30.95M | -$19.10M | -$27.62M | +34.8% |
| Dividends paid | -$10.98M | -$11.45M | -$36.37M | -$20.96M | +4.1% |
| Financing cash flow | -$15.84M | -$16.76M | -$40.71M | -$55.58M | +5.5% |
| Free cash flow | $15.74M | $19.18M | $22.33M | $26.43M | -17.9% |
| End cash position | $4.14M | $4.23M | $6.65M | $25.03M | -2.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $35.39M | $34.80M | $35.19M | $34.61M | $34.04M | +1.7% |
| Operating revenue | $35.39M | $34.80M | $35.19M | $34.61M | $34.04M | +1.7% |
| Cost of revenue | $13.56M | $13.65M | $13.94M | $12.40M | $12.97M | -0.6% |
| Gross profit | $21.83M | $21.16M | $21.26M | $22.20M | $21.06M | +3.2% |
| Selling, general & admin | $22.95M | $13.42M | $14.45M | $12.27M | $17.73M | +71.0% |
| Total operating expense | $25.07M | $15.59M | $16.59M | $14.47M | $19.48M | +60.8% |
| Operating income | -$3.24M | $5.57M | $4.67M | $7.74M | $1.59M | -158.1% |
| Net interest income | -$1.30M | -$1.22M | -$1.34M | -$1.42M | -$1.01M | -6.6% |
| Pre-tax income | -$4.54M | $4.38M | $3.27M | $6.27M | $581.00K | -203.6% |
| Tax provision | -$1.25M | $1.16M | $1.47M | $2.15M | $687.00K | -208.4% |
| Net income | -$3.28M | $3.22M | $1.80M | $4.12M | -$106.00K | -201.9% |
| Net income to common | -$3.30M | $3.22M | $1.49M | $4.12M | -$190.00K | -202.5% |
| Basic EPS | -0.15 | 0.14 | 0.08 | 0.18 | -0.01 | -207.1% |
| Diluted EPS | -0.15 | 0.14 | 0.08 | 0.18 | -0.01 | -207.1% |
| EBIT | -$3.22M | $5.63M | $4.64M | $7.73M | $1.61M | -157.1% |
| EBITDA | -$1.09M | $7.80M | $6.78M | $9.93M | $3.35M | -114.0% |
| Basic shares | 22.01M | 21.80M | 21.79M | 22.13M | 22.66M | +1.0% |
| Diluted shares | 22.01M | 21.91M | 21.81M | 22.13M | 22.66M | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.33M | $2.55M | $4.14M | $2.22M | $5.27M | +30.6% |
| Cash & short-term investments | $3.33M | $2.55M | $4.14M | $2.22M | $5.27M | +30.6% |
| Accounts receivable | $9.32M | $10.83M | $11.11M | $12.75M | $12.42M | -13.9% |
| Total current assets | $22.81M | $19.98M | $20.21M | $20.40M | $25.32M | +14.1% |
| Property, plant & equipment | $39.50M | $40.30M | $40.47M | $42.68M | $43.64M | -2.0% |
| Goodwill & intangibles | $68.25M | $68.32M | $68.38M | $68.48M | $68.57M | -0.1% |
| Total assets | $136.15M | $134.56M | $134.88M | $135.72M | $141.39M | +1.2% |
| Total current liabilities | $35.02M | $38.47M | $36.62M | $38.57M | $35.93M | -9.0% |
| Current debt | $4.02M | $4.01M | $4.01M | $4.01M | $3.93M | +0.0% |
| Long-term debt | $86.01M | $74.02M | $75.02M | $76.03M | $77.03M | +16.2% |
| Total debt | $90.03M | $78.03M | $79.03M | $80.04M | $80.96M | +15.4% |
| Total liabilities | $129.60M | $121.06M | $120.89M | $121.41M | $120.06M | +7.1% |
| Retained earnings | -$24.51M | -$17.68M | -$17.30M | -$15.47M | -$16.89M | -38.6% |
| Shareholder equity | $6.55M | $13.49M | $13.99M | $14.31M | $21.33M | -51.5% |
| Working capital | -$12.21M | -$18.49M | -$16.41M | -$18.16M | -$10.61M | +33.9% |
| Net tangible assets | -$61.71M | -$54.82M | -$54.39M | -$54.16M | -$47.25M | -12.6% |
| Shares issued | 22.14M | 31.98M | 31.97M | 31.95M | 31.78M | -30.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$3.28M | $3.22M | $1.80M | $4.12M | -$106.00K | -201.9% |
| Depreciation & amortisation | $2.12M | $2.17M | $2.15M | $2.19M | $1.74M | -2.2% |
| Stock-based compensation | $7.37M | $1.61M | $1.91M | $925.00K | $307.00K | +358.4% |
| Change in working capital | -$4.90M | $246.00K | -$1.38M | $6.54M | -$1.35M | -2,092.7% |
| Operating cash flow | $1.39M | $7.18M | $7.18M | $13.76M | -$1.14M | -80.7% |
| Capital expenditure | -$1.32M | -$1.83M | -$1.12M | -$3.59M | -$3.01M | +27.8% |
| Investing cash flow | -$1.32M | -$1.83M | -$1.12M | -$3.59M | -$3.01M | +27.8% |
| Share buybacks | -$7.64M | -$1.94M | -$1.00K | -$9.27M | -$5.99M | -295.0% |
| Dividends paid | -$3.61M | -$3.63M | -$2.70M | -$2.78M | -$2.73M | +0.5% |
| Financing cash flow | $718.00K | -$6.94M | -$4.14M | -$13.23M | $6.92M | +110.3% |
| Free cash flow | $62.00K | $5.35M | $6.06M | $10.18M | -$4.15M | -98.8% |
| End cash position | $3.33M | $2.55M | $4.14M | $2.22M | $5.27M | +30.6% |
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
20.00
-0.4% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
43
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
20.00
0 contracts
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.14 | 0.31 | +121.4% |
| Mar 2026 | — | 0.14 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.21 | 1 | $35.80M | — |
| Next quarter | 0.25 | 1 | $36.60M | — |
| Current year | 0.33 | 1 | $142.60M | — |
| Next year | 1.05 | 1 | $154.50M | +8.4% |
Analyst targets & ownership
Mean target$26.00
High target$26.00
Low target$26.00
Implied upside29.48%
Analyst count1
ConsensusNONE
Strong buy / Buy1 / 0
Hold0
Sell / Strong sell0 / 0
Held by insiders49.79%
Held by institutions50.37%
Institutions holding181
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
20.63
-2.68% from price
SMA 20
21.03
-4.50% from price
SMA 50
20.97
-4.23% from price
SMA 100
20.64
-2.70% from price
SMA 200
18.99
+5.75% from price
EMA 12
20.75
-3.23% from price
EMA 26
20.94
-4.12% from price
EMA 50
20.92
-4.01% from price
RSI (14)
43.9
Neutral
MACD (12,26,9)
-0.19
Hist -0.07
ATR (14)
1.03
5.13% of price
Realised vol 30D
48.0%
Annualised
Bollinger upper
22.44
20, 2σ
Bollinger lower
19.61
20, 2σ
50 / 200 cross
Golden
20.97 vs 18.99
Trend bias
Above 200
+5.75%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.55
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
48.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-46.5%
Peak to trough
Max drawdown 5Y
-79.3%
Peak to trough
ATR 14
1.03
5.13% of price
Beta (reported)
0.28
5Y monthly, from filing
Short interest
Shares short
685.38K
Prior 554.32K
Change vs prior
+23.6%
Shorts adding
% of float
28.48%
Heavily shorted
% of shares out
3.10%
Against total outstanding
Days to cover
5.8
Crowded exit
Float
11.82M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 29, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Jun 22, 26 | Citizens | INITIATED | — | Market Outperform |
Dividends & splits
Forward rate$0.64 / yr
Forward yield3.18%
5-year avg yield1.84%
Payout ratio250.00%
Ex-dividend dateSep 25, 2026
Next pay dateOct 9, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-11
Periodic Financial Reports
10-Q · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-07-28
Corporate Changes & Voting Matters
8-K · 2026-06-29
Annual Report to Shareholders
ARS · 2026-05-08
Periodic Financial Reports
10-Q · 2026-05-06
Proxy Statements
PRE 14A · 2026-04-28
Corporate Changes & Voting Matters
8-K · 2026-04-20
Headlines
NRC Health Trades at a Discount: Should You Buy, Sell or Hold?
Zacks · 9d ago
NRC Health's Dividend Analysis
GuruFocus.com · 12d ago
The Governance Institute Blue Ribbon Committee Reframes Hospital and Health System Board Assessment with Four Considerations for Stronger Governance
Business Wire · 16d ago
KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
Business Wire · 34d ago
NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare
Business Wire · 36d ago
Resideo Technologies Names New CFO
MT Newswires · 55d ago
Resideo Appoints Shane Harrison as Chief Financial Officer
PR Newswire · 55d ago
Record Backlog Powers NRC Health’s (NRC) Upward Potential
Insider Monkey · 58d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.